Roche’s Carmot Takeover: Tackling Obesity, Potential Drugs Await Until 2030
Swiss pharmaceuticals giant Roche is set to acquire anti-obesity drug developer Carmot Therapeutics, becoming the latest company to attempt to unseat Novo Nordisk and Eli […]